| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V70099 | (Thr(PO3H2)231)-Tau Peptide (225-237) | 1670270-09-3 | (Thr(PO3H2)231)-Tau Peptide (225-237) is a fragment of the tau peptide. |
|
V77297 | Acetyl-PHF6 amide TFA (AcPHF6 TFA; Ac-VQIVYK-NH2 TFA) | Acetyl-PHF6 amide TFA (AcPHF6 TFA) is a tau-derived hexapeptide. | |
|
V70096 | Acetyl-Tau Peptide (244-274) (Repeat 1 Domain) | 2022956-56-3 | Acetyl-Tau Peptide (244-274) (Repeat 1 Domain) is a bioactive peptide discovered by peptide screening. |
|
V133928 | Diranersen | 2304711-06-4 | Diranersen is an antisense oligonucleotide that targets the human MAPT gene to inhibit the production of tau protein. |
|
V109418 | Dopegal | 13023-73-9 | Dopamine is a metabolite of norepinephrine. |
|
V96684 | GSK-3β inhibitor 21 | GSK-3β inhibitor 21 (compound 44) is an ATP-competitive GSK-3β inhibitor (IC50=6.06 μM) with anti-amyloid aggregation and tau phosphorylation inhibitory activities. | |
|
V119648 | Moponetug | 3031519-40-8 | Moponetug is a humanized IgG1κ antibody that targets MAPT, with a corresponding isotype control being the human IgG1 kappa isotype control. |
|
V144827 | SGK1-IN-7 | 3109982-58-0 | SGK1-IN-7 is an SGK1 inhibitor that can cross the blood-brain barrier, with an IC50 value of 0.72 μM. |
|
V145608 | Tau ASO-12 (murine) sodium scrambled negative control | The Tau ASO-12 (murine) sodium scrambled negative control is a negative control for Tau ASO-12 (murine) sodium with a scrambled sequence. | |
|
V145609 | Tau ligand-1 | 3063166-64-0 | Tau ligand-1 is an aggregated tau protein ligand that can cross the blood-brain barrier. |
|
V145610 | Tau ligand-2 | 3046416-94-5 | Tau ligand-2 is a tau protein aggregate ligand with a Ki value of 0.99 nM. |
|
V70086 | Tau Peptide (1-16) (human) | 2022956-53-0 | Tau Peptide (1-16) (human) is a fragment of Tau protein. |
|
V70104 | Tau Peptide (244-274) (Repeat 1 Domain) | 330456-24-1 | Tau Peptide (244-274) (Repeat 1 Domain) is a fragment of Tau protein. |
|
V87851 | Tau-aggregation-IN-3 | 3032869-59-0 | Tau-aggregation-IN-3 (compound 9) is a Tau protein aggregation inhibitor (TAI). |
|
V145611 | TAU-IN-3 | 3063511-09-8 | TAU-IN-3 is an orally effective TAU inhibitor. |
|
V145612 | TAU-IN-4 | 2109305-45-3 | TAU-IN-4 is a potent inhibitor of Tau protein aggregation with a KD value of 1.58 μM. |
|
V145613 | TAU-IN-6 | 3083792-74-6 | TAU-IN-6 is an inhibitor of Tau protein misfolding and aggregation. |
|
V145645 | TBL-100 | TBL-100 is a human monoclonal antibody (mAb) that targets the Tau protein. | |
|
V146606 | TTBK1/2-IN-1 | 2342571-09-7 | TTBK1/2-IN-1 is a potent inhibitor of Tau tubulin kinase 1 (TTBK1) and TTBK2, with IC50 values of 816 nM and 384 nM, respectively. |
|
V146607 | TTBK1/2-IN-2 | 2857982-35-3 | TTBK1/2-IN-2 is a potent inhibitor of Tau tubulin kinase 1 (TTBK1) and TTBK2, with IC50 values of 384 nM and 175 nM, respectively. |